ABSTRACT
INTRODUCTION
Clinical specimens derived from biological fluids, such as blood or tissue lysates, often contain impurities that inhibit PCR and lead to false-negative results in PCR-based assays (8, 9) . In addition, amplification failures may occur through loss of nucleic acids during extraction procedures, technical errors or mistakes in setting up the PCR. Thus, using an internal control that is added before PCR or before extracting nucleic acid is advantageous to avoid false-negative results (8, 9) . Internal controls are usually obtained by different PCR manipulations such as amplification and modification of specific gene sequences.
They are then used either directly after purification of the PCR products (4) or, more often, after additional cloning into plasmids (9) . The time and labor required for these steps are likely the main reasons that internal controls have rarely been used for qualitative PCR in routine settings. The purpose of this study was to develop a simpler method for the construction of internal controls to enhance their acceptance.
MATERIALS AND METHODS

ssDNA Virus Parvo B19
Parvo B19 DNA was extracted from a sample containing B19 virus using a blood kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. The DNA was then eluted with 50-µ L distilled water, and predetermined amounts were subjected to PCR.
ssDNA Virus TTV
TTV is a novel DNA virus that was isolated in 1997 from the serum of a patient (TT) with post-transfusion hepatitis of unknown etiology, and designated TT virus (6, 7) . For the determination of TTV, DNA was extracted with the same procedure from 200 µ L pooled citrated plasma from 32 healthy donors. Before the extraction, approximately 50 copies of the single-stranded control TTVc were added to the plasma pools. Finally, 15-µ L aliquots were subjected to PCR.
dsDNA (FVIII) from Crude Lysates of Mouse Tail Pieces
Pieces of tail approximately 5 mm in length were digested for 5 h at 55°C in 600 µ L lysis buffer containing 10 mM Tris-HCl (pH 8.3), 2 mM MgCl 2 , 0.01% Nonidet ® P-40 (Sigma, St.
Louis, MO, USA) and 200 µ g/mL proteinase K (Roche Molecular Biochemicals, Mannheim, Germany). The enzyme was heat-inactivated for 10 min at 94°C, and 3 µ L of the lysate were subjected directly to PCR. Table 1 shows the sequences of custom-synthesized oligonucleotides (MWG-Biotech, Ebersberg, Germany) that were used as the internal controls.
Internal Controls
PCR
One to three microliters of a tenfold dilution of the B19 sample, 15 µ L of the extracted TTV DNA samples and 3 µ L tail-piece lysates were subjected to a single-stage internally controlled PCR using a thermally activated DNA polymerase (HotStarTaq ™; Qiagen).
Reactions were carried out in a total volume of 50 µ L. The solution contained 1 U of the polymerase in the buffer supplied by the manufacturer, 200 µ M dNTP and 50 pmol of the appropriate primer pair for the target DNA (B19, TTV and FVIII knockout mice, Table 1 ). Internal controls were added to the TTV samples before the extraction procedure; for the B19 samples and the tail lysates, the internal controls were added to the respective reaction tubes just before PCR. Samples were then overlaid with mineral oil, incubated for 14 min at 94°C and amplified for 45 cycles in a TRIOThermoblock ® (BioMetra, Göttingen, Germany) with the following profile: 30 s at 94°C, 30 s at 55°C, 60 s at 72°C and a final step at 72°C for 1 min. The samples were fractionated on a 3.5% low-melting agarose gel stained with ethidium bromide. 
RESULTS AND DISCUSSION
The internal controls contained the forward primer sequences and the complementary sequences of the reverse primer for the DNA to be tested. A randomly chosen DNA sequence appears between the primer sequences. After determining the desired sequence of the internal control, we ordered a customsynthesized, single-stranded oligonucleotide instead of carrying out timeconsuming and cumbersome manipulations on the target DNA to achieve this sequence.
A TaqDNA polymerase, inactive at room temperature and activated above 94°C, was used to achieve the highest possible sensitivity and specificity in the single-stage PCR protocol. We initially tested the use of a single-stranded, custom-synthesized internal control in a PCR setup for the detection of ssDNA virus Parvo B19. Parvo B19 causes a common childhood illness that is usually mild in immunocompetent people, but is implicated in erythema infectiosum, transient aplastic crisis in patients with hemolytic anemia, fetal death, arthritis and chronic anemia (1) . DNA from a sample containing the virus was extracted and then serially diluted tenfold. Of the last two dilutions, 1 and 3.3 µ L were subjected to PCR with or without approximately 10 copies (the lowest amount for which PCR amplification products could always be achieved) of internal control B19c. Figure 1A shows bands of the expected size both for samples without (lanes 2-5) or in the presence of the internal control (117 bp, lanes 6-9). Note that the lowest concentration of B19 visible without internal control (lane 4) was still clearly visible if mixed with B19c (lane 8).
The detection of TTV was then chosen to test the usefulness of a singlestranded oligonucleotide as the internal control for a nucleic acid co-extraction procedure. Because recovery was less than 100% during DNA extraction, it was necessary to add approximately 50 copies of the internal control TTVc before extraction of TTV DNA to achieve positive PCR amplification products. The samples were extracted and then subjected to PCR. Representative results are given in Figure 1B , in which a The
gene into the 3 ′ -end of exon 17 of the factor VIII gene. One of our breeding strategies is crossbreeding normal C57BL/6 females with hemizygous affected knockout males (5) . Crude lysates of tail pieces are genotyped to determine the zygosity of the offspring. The internal control was an oligonucleotide containing the sequence of MC18 and the complementary sequences of neo2R and MC19. As for Parvo B19, approximately 10 copies of FVIIIc added before PCR was the lowest number to always achieve PCR signals. Figure 1C shows a typical example of a genotyping experiment performed with two selected samples from het - erozygous (X′ X) females. Both samples were amplified alone or in the presence of the internal controls with either primer pair MC18/MC19 or MC18/ neoR2. Sample 1 (lanes 2, 3, 8 and 9 ) showed all the expected bands of the specific template and the internal control with both primer pairs; sample 2 (lanes 4, 5, 10 and 11), which apparently contained PCR inhibitors, resulted in only faint bands with MC18/neoR2 (lanes 10 and 11) and no bands with MC18/MC19 (lanes 4 and 5). Thus, only the use of the internal control prevented a false determination of the genotype. It has been recommended that the size difference between the specific template and the internal control should be kept to a minimum (9) . However, despite the large difference in size between the specific 680 bp template and the 105 bp of the internal control (MC18/MC19), both PCR products were clearly visible after amplification in this setup.
Short Technical Reports
In summary, internal controls constructed using custom-synthesized oligonucleotides proved to be a useful tool for PCR with both ssDNA and dsD -NA. The method was sufficiently sensitive for the detection of a low number of copies of the specific template. Because construction of internal controls through PCR manipulation and cloning procedures can be laborious and costly, we believe our approach may save considerable time and money. Quite possibly, this method can be easily adapted with new primer sequences for any PCR.
INTRODUCTION
Retroviruses are efficient vehicles for delivering foreign genes into mammalian cells. When conditions are properly controlled, it is possible to achieve infection rates approaching 100% in cultured cells. Retroviruses can deliver genes to cells that are refractory to other methods of gene delivery, such as transfection and electroporation, and they do not discriminate between cells that grow in suspension and cells that require solid support. The retrovirus gene delivery system is bipartite and consists of the vector and a packaging cell line that furnishes proteins necessary for the encapsidation of the vector genome RNA into infectious particles and its eventual integration as DNA into the genome of the target cell.
Several excellent reviews describe in depth the utility and limitations of retroviruses as shuttle vectors, their structure and life cycle (3, 5, 6, 18, 26) . Since the introduction of retroviruses as gene delivery vehicles, modifications have been introduced to address deficiencies in gene expression and regulation, viral titer and host range specificity that, at one time, placed restrictions on their usefulness. Retroviral vectors that are currently in use incorporate one or more of these technological advances described below.
Apart from the long terminal repeats (LTRs) and the packaging signal sequence, a retroviral cloning vector can accommodate 6-7 kb of DNA. A portion of this space is often reserved for a gene that encodes either a drug-selectable or histochemical marker. The remaining space is devoted to the gene of interest. Two strategies have been devised to ensure that both genes are expressed, and these are illustrated by the LX (18), rkat (9) and pCL vectors (19). In addition to the LTR, the LX vectors contain a strong internal promoter that is situated between the multiple cloning site and the selectable marker. Thus, two types of transcripts are produced: a genome-length transcript that initiates at the LTR and encodes both the gene of interest and a selectable marker, and a subgenomic transcript that initiates at the internal promoter and contains only the selectable marker.
If The efficiency of a promoter may be reduced by the presence of another promoter, a phenomenon known as promoter interference (8) . The most recent generation of retroviral vectors addresses this problem by taking advantage of the viral DNA replication mechanism. The 3 ′ LTR of the RNA is the template for the 5 ′ LTR during DNA synthesis and proviral integration. The promoter region is deleted from the 3 ′ LTR of the self-inactivating class of retroviral vectors (28). A genomelength RNA transcript that contains a nonfunctional promoter within the 3 ′ LTR is the template of a provirus that contains a nonfunctional 5 ′ LTR. Thus, only one transcript arises from the provirus, and it initiates at the internal enhancer/promoter. This report describes a family of retroviral Q vectors that incorporate technological advances found within the aforementioned constructs. Included within each of these vectors is an E1A responsive hybrid CMV/murine sarcoma virus (MSV) 5 ′ LTR, an internal CMV enhancer/promoter or IRES, an SV40 ori and a multiple cloning site that contains more restriction sites than other retroviral vectors. When expressed within an appropriate packaging cell line, Q vectors produce retrovi -
